Educational Tools for Neonatal Screening Consent
(MICI Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a new method to help new mothers understand and consent to the use of leftover blood samples from their babies for research, known as the Michigan BioTrust. The study compares current education methods—a brief talk and brochure—with a new electronic format that includes an educational website and video. The goal is to determine if the new tools make the consent process clearer and more effective for both mothers and hospital staff. Women who have just given birth and speak English, Spanish, or Arabic may qualify if they are still in the Mother & Baby Unit and their newborn is not in intensive care or up for adoption. As an unphased trial, this study offers participants the opportunity to contribute to improving consent processes for future parents.
Do I need to stop my current medications for this trial?
The trial protocol does not specify whether you need to stop taking your current medications.
What prior data suggests that this electronic consent education process is safe for neonatal screening consent?
Research has shown that educational tools like websites and videos for informed consent are safe and effective. One study tested a process called dynamic consent with an educational website and found it helped participants understand their choices without harm. Another project used a video to explain newborn screening and found it improved knowledge without negative effects.
These educational tools are simple and easy to use. They provide clear information to help people make informed decisions, focusing on improving understanding rather than causing stress or confusion. Overall, the tools have been well-received, with no reports of negative side effects.12345Why are researchers excited about this trial?
Researchers are excited about this trial because it explores how digital tools can enhance understanding and consent in neonatal screening. Unlike the standard approach, which includes a brief verbal explanation and a brochure, the new method offers an engaging website and a concise video. These digital resources aim to provide more comprehensive and accessible information, potentially leading to better-informed decision-making by parents. By presenting information in multiple languages and through different media, the trial hopes to determine if these tools improve comprehension and satisfaction with the consent process.
What evidence suggests that this educational process is effective for neonatal screening consent?
Research has shown that tools like videos and websites can clarify and engage patients in the consent process. In this trial, participants in the intervention arm will receive standard care along with access to an educational website and a 4-minute video about the Michigan BioTrust. One study found that using a video improved understanding of the process without reducing support for newborn screening. Another study discovered that electronic consent tools help people make informed decisions about using leftover blood samples for research. These tools simplify complex information, making it easier to understand and remember. Overall, educational videos and websites show promise in improving how consent is obtained and understood.12467
Who Is on the Research Team?
Erin Rothwell, MD
Principal Investigator
University of Utah
Are You a Good Fit for This Trial?
This trial is for adults over 18 who speak English, Spanish or Arabic and have just given birth at one of the four participating hospitals in Michigan. They should be patients in the Mother & Baby Unit and willing to provide feedback on a new consent process for using leftover blood samples from newborn screening.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Pre-implementation Data Collection
Participants complete surveys about the BioTrust consent process before the new education process is implemented
Implementation and Intervention
Hospital staff provide access to a website with detailed information and a video about the Michigan BioTrust; participants complete surveys immediately after
Follow-up
Participants are monitored for decisional regret, decisional conflict, and knowledge scores at 4 weeks post-intervention
Post-implementation Data Collection
Hospital consenting and biobanking rates are obtained from state data 6 months after the end of data collection
What Are the Treatments Tested in This Trial?
Interventions
- Educational Website and Video
Find a Clinic Near You
Who Is Running the Clinical Trial?
Erin Rothwell
Lead Sponsor
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Collaborator